MACK Merrimack Pharmaceuticals, Inc.

3.18
-0.01  -0.31%
Previous Close 3.19
Open 3.19
Price To book 0.00
Market Cap 412.18M
Shares 129,615,000
Volume 1,123,509
Short Ratio 4.68
Av. Daily Volume 3,620,960

Drug Information

Drug catalyst information is displayed when you hover over the stage bar graph.

Approved October 22 2015
ONIVYDE
Cancer - second line pancreatic
Phase 2 data due 1H 2018.
MM-141
Cancer - front line pancreatic cancer
Phase 2 trial discontinued December 21, 2016 due to poor efficacy.
MM-302 HERMIONE
Cancer - HER2-positive locally advanced or metastatic breast cancer
Phase 2 initiated mid Feb 2015. Data due by end of 2018.
MM-121
Cancer - Heregulin Positive Non-Small Cell Lung Cancer
Acquired by Ipsen
ONIVYDE
Cancer - HER2-negative gastric cancer
Acquired by Ipsen
ONIVYDE
Cancer - front line pancreatic

Latest News

  1. Merrimack (MACK): What Awaits the Stock in Q4 Earnings?
  2. Is Merrimack Pharmaceuticals Worth Stashing in Portfolios?
  3. 3 Stocks Begging for a Buyout
  4. Merrimack Pharmaceuticals employee arrested, charged with insider trading
  5. Merrimack Pharma employee arrested on U.S. insider trading charge
  6. UPDATE 1-Merrimack Pharma employee arrested on U.S. insider trading charge
  7. Biotech employee arrested, accused by U.S. of insider trading
  8. MERRIMACK PHARMACEUTICALS INC Files SEC form 8-K, Termination of a Material Definitive Agreement, Change in Directors
  9. Why Merrimack Pharmaceuticals Got Crushed 23.8% in January
  10. MERRIMACK PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers
  11. Here Are the Biotech Stocks Moving Ahead of the Opening Bell
  12. MERRIMACK PHARMACEUTICALS INC Files SEC form 8-K, Change in Directors or Principal Officers
  13. Merrimack Names Richard Peters, M.D., Ph.D., as President and CEO
  14. Merrimack (MACK) Goes Uphill: Is a Turnaround Likely?
  15. DryShips, Alcobra Sink into Tuesday’s 52-Week Low Club
  16. Merrimack Pharmaceuticals Prospects for the New MACK and Review
  17. Latest Reports on Diffusion and Merrimack as Drug Stocks are Hit by President Trump's Comments
  18. Macy’s, Teva Join Wednesday’s 52-Week Low Club
  19. Is the Options Market Predicting a Spike in Merrimack (MACK) Stock?
  20. DryShips, Merrimack Pharma Stuck in Tuesday’s 52-Week Low Club